Considerations for Proper Use of Hyaluronidase in the Management of Hyaluronic Acid Fillers.

Kyu-Ho Yi, Jovian Wan, Song Eun Yoon
Author Information
  1. Kyu-Ho Yi: From the Division in Anatomy and Developmental Biology, Department of Oral Biology, Human Identification Research Institute, BK21 FOUR Project, Yonsei University College of Dentistry, Seoul, Korea.
  2. Jovian Wan: Medical Research, Inc., Wonju, Korea.
  3. Song Eun Yoon: BRANDNEW Aesthetic Surgery Clinic, Seoul, Korea.

Abstract

Effective management of complications from hyaluronic acid (HA) fillers is crucial in aesthetic medicine. This article examined the role of hyaluronidase in addressing adverse effects associated with HA fillers, such as nodules, vascular occlusions, and excessive volume. It highlights the enzyme's ability to degrade HA, thereby resolving issues that may arise from filler treatments. The discussion includes practical aspects of using hyaluronidase, such as recommended dosing, injection techniques, and potential risks. The benefits of hyaluronidase, including its rapid action in dissolving problematic fillers and its role in improving patient outcomes, are explored. The article also addresses limitations and safety considerations to provide a comprehensive understanding of hyaluronidase in the context of filler complications. By offering insights into the application and effectiveness of hyaluronidase, this article aimed to enhance practitioners' ability to manage HA filler-related issues effectively and ensure optimal results in aesthetic procedures.

References

  1. Aesthet Surg J. 2014 May 1;34(4):584-600 [PMID: 24692598]
  2. Plast Reconstr Surg. 2009 Jun;123(6):1842-1863 [PMID: 19483587]
  3. Infect Immun. 2016 May 24;84(6):1917-1929 [PMID: 27068096]
  4. Pathog Dis. 2014 Apr;70(3):339-46 [PMID: 24482426]
  5. J Clin Aesthet Dermatol. 2014 Sep;7(9):37-43 [PMID: 25276276]
  6. FASEB J. 2016 Jun;30(6):2108-14 [PMID: 26887442]
  7. Aesthet Surg J. 2006 May-Jun;26(3):356-64 [PMID: 19338919]
  8. Int J Mol Sci. 2022 Sep 10;23(18): [PMID: 36142430]
  9. J Clin Aesthet Dermatol. 2018 Jun;11(6):E61-E68 [PMID: 29942426]
  10. J Cosmet Laser Ther. 2015;17(6):335-42 [PMID: 25968167]
  11. Aesthet Surg J. 2013 May;33(4):561-75 [PMID: 23636629]
  12. Matrix Biol. 2001 Dec;20(8):499-508 [PMID: 11731267]
  13. Tissue Eng Regen Med. 2023 Jun;20(3):503-517 [PMID: 37041433]
  14. Plast Reconstr Surg. 2017 Mar;139(3):613-621 [PMID: 28234833]
  15. JMIR Dermatol. 2024 Jan 17;7:e50403 [PMID: 38231537]
  16. Plast Reconstr Surg Glob Open. 2020 Oct 28;8(10):e3219 [PMID: 33173709]
  17. Clin Cosmet Investig Dermatol. 2013 Dec 12;6:295-316 [PMID: 24363560]
  18. Pharmaceutics. 2021 Oct 20;13(11): [PMID: 34834156]
  19. J Clin Aesthet Dermatol. 2018 May;11(5):E53-E55 [PMID: 29785240]
  20. J Eur Acad Dermatol Venereol. 2008 Feb;22(2):150-61 [PMID: 18211407]
  21. Clin Interv Aging. 2007;2(4):509-19 [PMID: 18225451]
  22. J Clin Aesthet Dermatol. 2020 Jan;13(1):E53-E58 [PMID: 32082474]
  23. J Plast Reconstr Aesthet Surg. 2011 Dec;64(12):1590-5 [PMID: 21807574]
  24. Clujul Med. 2013;86(3):192-5 [PMID: 26527945]
  25. Dermatol Surg. 2015 Aug;41(8):929-39 [PMID: 26166260]
  26. Dermatol Surg. 2015 Dec;41 Suppl 1:S354-7 [PMID: 26618464]
  27. Aesthetic Plast Surg. 2012 Apr;36(2):421-6 [PMID: 21909864]
  28. Clin Cosmet Investig Dermatol. 2021 Sep 08;14:1175-1199 [PMID: 34526796]
  29. Dermatol Surg. 2015 Oct;41(10):1097-117 [PMID: 26356847]
  30. Dermatol Ther. 2016 Jan-Feb;29(1):41-4 [PMID: 26814449]
  31. Dermatol Surg. 2015 Dec;41 Suppl 1:S347-53 [PMID: 26618463]
  32. Aesthet Surg J. 2024 May 15;44(6):647-657 [PMID: 38262634]
  33. Dermatol Surg. 2016 Jan;42(1):31-7 [PMID: 26655699]
  34. J Biomed Mater Res A. 2008 Oct;87(1):264-71 [PMID: 18200557]
  35. Aesthet Surg J. 2017 Jul 1;37(7):814-825 [PMID: 28333326]
  36. J Cutan Aesthet Surg. 2010 Jan;3(1):20-2 [PMID: 20606988]
  37. J Drugs Dermatol. 2016 May 1;15(5):600-6 [PMID: 27168268]
  38. J Plast Reconstr Aesthet Surg. 2012 Jan;65(1):29-34 [PMID: 21885359]
  39. Aesthet Surg J. 2013 Aug 1;33(6):862-77 [PMID: 23825309]
  40. Plast Reconstr Surg. 2014 Dec;134(6):1197-1201 [PMID: 25415089]
  41. Aesthet Surg J. 2015 Sep;35(7):844-9 [PMID: 25964629]
  42. Am J Clin Dermatol. 2013 Oct;14(5):401-11 [PMID: 24037757]
  43. Arch Plast Surg. 2015 Mar;42(2):232-9 [PMID: 25798398]
  44. Arch Plast Surg. 2020 Jul;47(4):297-300 [PMID: 32718106]
  45. Eur J Nucl Med Mol Imaging. 2013 Feb;40(3):418-25 [PMID: 23208702]
  46. Eur J Med Res. 2016 Feb 13;21:5 [PMID: 26873038]

Word Cloud

Created with Highcharts 10.0.0hyaluronidaseHAfillersarticlecomplicationsaestheticroleabilityissuesfillerEffectivemanagementhyaluronicacidcrucialmedicineexaminedaddressingadverseeffectsassociatednodulesvascularocclusionsexcessivevolumehighlightsenzyme'sdegradetherebyresolvingmayarisetreatmentsdiscussionincludespracticalaspectsusingrecommendeddosinginjectiontechniquespotentialrisksbenefitsincludingrapidactiondissolvingproblematicimprovingpatientoutcomesexploredalsoaddresseslimitationssafetyconsiderationsprovidecomprehensiveunderstandingcontextofferinginsightsapplicationeffectivenessaimedenhancepractitioners'managefiller-relatedeffectivelyensureoptimalresultsproceduresConsiderationsProperUseHyaluronidaseManagementHyaluronicAcidFillers

Similar Articles

Cited By